{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:29:20Z","timestamp":1766068160478,"version":"3.48.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10151-024-03082-3","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:19:38Z","timestamp":1737609578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The oncologic benefits of lateral lymph node dissection after neoadjuvant therapy \u2013 local control or survival?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4918-8871","authenticated-orcid":false,"given":"T.","family":"Sammour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"3","key":"3082_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0002-9610(82)90018-6","volume":"144","author":"K Hojo","year":"1982","unstructured":"Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144(3):350\u2013354","journal-title":"Am J Surg"},{"issue":"1","key":"3082_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1200\/JCO.18.00032","volume":"37","author":"A Ogura","year":"2019","unstructured":"Ogura A et al (2019) Neoadjuvant (Chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3\/4 rectal cancer. J Clin Oncol 37(1):33\u201343","journal-title":"J Clin Oncol"},{"issue":"5","key":"3082_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ags3.12197","volume":"2","author":"T Sammour","year":"2018","unstructured":"Sammour T, Chang GJ (2018) Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: mutually exclusive or mutually beneficial? Ann Gastroenterol Surg 2(5):348\u2013350","journal-title":"Ann Gastroenterol Surg"},{"key":"3082_CR4","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3389\/fonc.2019.01355","volume":"9","author":"A Haanappel","year":"2019","unstructured":"Haanappel A et al (2019) Lateral lymph node metastases in locally advanced low rectal cancers may not be treated effectively with neoadjuvant (Chemo)radiotherapy only. Front Oncol 9:1355","journal-title":"Front Oncol"},{"issue":"7","key":"3082_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.ejso.2022.04.016","volume":"48","author":"HM Kroon","year":"2022","unstructured":"Kroon HM et al (2022) Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer. Eur J Surg Oncol 48(7):1475\u20131482","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"3082_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3393\/ac.2024.00521.0074","volume":"40","author":"GS Choi","year":"2024","unstructured":"Choi GS, Kim HJ (2024) The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes. Ann Coloproctol 40(4):363\u2013374","journal-title":"Ann Coloproctol"},{"key":"3082_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jss.2021.06.002","volume":"267","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Prognostic value of lateral pelvic lymph node dissection for rectal cancer: a meta-analysis. J Surg Res 267:414\u2013423","journal-title":"J Surg Res"},{"issue":"9","key":"3082_CR8","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1245\/s10434-023-13460-0","volume":"30","author":"TC Sluckin","year":"2023","unstructured":"Sluckin TC et al (2023) Evaluation of National surgical practice for lateral lymph nodes in rectal cancer in an untrained setting. Ann Surg Oncol 30(9):5472\u20135485","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3082_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10151-015-1266-9","volume":"19","author":"I Shaikh","year":"2015","unstructured":"Shaikh I et al (2015) Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall. Tech Coloproctol 19(2):119\u2013120","journal-title":"Tech Coloproctol"},{"issue":"11","key":"3082_CR10","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.ejso.2021.11.003","volume":"48","author":"SJA Hazen","year":"2022","unstructured":"Hazen SJA et al (2022) Lateral lymph node dissection in rectal cancer: State of the art review. Eur J Surg Oncol 48(11):2315\u20132322","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3082_CR11","first-page":"226","volume":"35","author":"AA Iv","year":"2022","unstructured":"Iv AA et al (2022) The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation. Ann Gastroenterol 35(3):226\u2013233","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"3082_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12885-024-11867-w","volume":"24","author":"Z Xie","year":"2024","unstructured":"Xie Z et al (2024) Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China. BMC Cancer 24(1):115","journal-title":"BMC Cancer"},{"issue":"9","key":"3082_CR13","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ejso.2021.06.004","volume":"47","author":"HM Kroon","year":"2021","unstructured":"Kroon HM et al (2021) Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: an international multi-centre comparative study. Eur J Surg Oncol 47(9):2441\u20132449","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3082_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12885-022-09254-4","volume":"22","author":"S Zhou","year":"2022","unstructured":"Zhou S et al (2022) Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study. BMC Cancer 22(1):136","journal-title":"BMC Cancer"},{"issue":"2","key":"3082_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1245\/s10434-021-10815-3","volume":"29","author":"HM Kroon","year":"2022","unstructured":"Kroon HM, Kusters M, Sammour T (2022) ASO author reflection: lateral pelvic lymph nodes in rectal cancer-not all are created equal. Ann Surg Oncol 29(2):1204\u20131205","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"3082_CR16","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1007\/s00261-023-03893-2","volume":"48","author":"S Lee","year":"2023","unstructured":"Lee S et al (2023) Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of abdominal radiology colorectal and anal cancer disease-focused panel. Abdom Radiol (NY) 48(9):2792\u20132806","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"3082_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/DCR.0000000000002640","volume":"67","author":"S Zhou","year":"2024","unstructured":"Zhou S et al (2024) Feasibility, indications, and prognostic significance of selective lateral pelvic lymph node dissection after preoperative chemoradiotherapy in middle\/low rectal cancer: results of a multicenter lateral node study in China. Dis Colon Rectum 67(2):228\u2013239","journal-title":"Dis Colon Rectum"},{"key":"3082_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916285","volume":"12","author":"S Zhou","year":"2022","unstructured":"Zhou S et al (2022) Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: results of a large multicenter lateral node collaborative group in China. Front Oncol 12:916285","journal-title":"Front Oncol"},{"issue":"9","key":"3082_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.2172","volume":"154","author":"A Ogura","year":"2019","unstructured":"Ogura A et al (2019) Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 154(9):e192172","journal-title":"JAMA Surg"},{"key":"3082_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad449","author":"M Kusters","year":"2024","unstructured":"Kusters M (2024) Lateral pelvic lymph nodes in rectal cancer: a multi-disciplinary team effort is needed to prevent local recurrence. Br J Surg. https:\/\/doi.org\/10.1093\/bjs\/znad449","journal-title":"Br J Surg"},{"issue":"2","key":"3082_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/bjs\/znaa009","volume":"108","author":"DP Schaap","year":"2021","unstructured":"Schaap DP et al (2021) Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg 108(2):205\u2013213","journal-title":"Br J Surg"},{"issue":"1","key":"3082_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.6004\/jnccn.2023.7081","volume":"22","author":"EGM van Geffen","year":"2024","unstructured":"van Geffen EGM et al (2024) Value of size and malignant features of lateral lymph nodes in risk stratification at lateral local recurrence of rectal cancer: a National Cohort Study. J Natl Compr Canc Netw 22(1):17\u201325","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"3082_CR23","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1245\/s10434-021-10762-z","volume":"29","author":"HM Kroon","year":"2022","unstructured":"Kroon HM et al (2022) Malignant features in pretreatment metastatic lateral lymph nodes in locally advanced low rectal cancer predict distant metastases. Ann Surg Oncol 29(2):1194\u20131203","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3082_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/bjs\/znad115","volume":"110","author":"O Peacock","year":"2023","unstructured":"Peacock O et al (2023) Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything. Br J Surg 110(8):985\u2013986","journal-title":"Br J Surg"},{"issue":"7","key":"3082_CR25","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.ejso.2022.01.030","volume":"48","author":"Y Fukui","year":"2022","unstructured":"Fukui Y et al (2022) Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: an international retrospective cohort study. Eur J Surg Oncol 48(7):1631\u20131637","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3082_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12893-021-01443-5","volume":"21","author":"S Zhou","year":"2021","unstructured":"Zhou S et al (2021) Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis. BMC Surg 21(1):441","journal-title":"BMC Surg"},{"issue":"1\u20132","key":"3082_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ans.18021","volume":"93","author":"S Bedrikovetski","year":"2023","unstructured":"Bedrikovetski S et al (2023) Personalized total neoadjuvant therapy (pTNT) for advanced rectal cancer with tailored treatment sequencing based on clinical stage at presentation. ANZ J Surg 93(1\u20132):173\u2013181","journal-title":"ANZ J Surg"},{"issue":"4","key":"3082_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/SLA.0000000000005589","volume":"276","author":"O Peacock","year":"2022","unstructured":"Peacock O et al (2022) Magnetic resonance imaging directed surgical decision making for lateral pelvic lymph node dissection in rectal cancer after Total Neoadjuvant Therapy (TNT). Ann Surg 276(4):654\u2013664","journal-title":"Ann Surg"},{"issue":"1","key":"3082_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1245\/s10434-013-3216-y","volume":"21","author":"T Akiyoshi","year":"2014","unstructured":"Akiyoshi T et al (2014) Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 21(1):189\u2013196","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3082_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/DCR.0000000000000752","volume":"60","author":"S Ishihara","year":"2017","unstructured":"Ishihara S et al (2017) Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum 60(5):469\u2013476","journal-title":"Dis Colon Rectum"},{"issue":"59","key":"3082_CR31","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.18632\/oncotarget.20121","volume":"8","author":"HJ Kim","year":"2017","unstructured":"Kim HJ et al (2017) Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer. Oncotarget 8(59):100724\u2013100733","journal-title":"Oncotarget"},{"issue":"9","key":"3082_CR32","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1245\/s10434-020-08481-y","volume":"27","author":"MJ Kim","year":"2020","unstructured":"Kim MJ et al (2020) Oncological impact of lateral lymph node dissection after preoperative chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol 27(9):3525\u20133533","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3082_CR33","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/codi.15176","volume":"22","author":"HG Jones","year":"2020","unstructured":"Jones HG et al (2020) Incidence and treatment of positive pelvic sidewall lymph nodes in patients with rectal cancer. Colorectal Dis 22(11):1560\u20131567","journal-title":"Colorectal Dis"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-024-03082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-024-03082-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-024-03082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:58:22Z","timestamp":1766051902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-024-03082-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3082"],"URL":"https:\/\/doi.org\/10.1007\/s10151-024-03082-3","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"type":"print","value":"1123-6337"},{"type":"electronic","value":"1128-045X"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"51"}}